HomeNuCryo Vascular LLC

NuCryo Vascular LLC

NuCryo Vascular Announces Commercialization Agreement with Lokai Medical for Innovative Treatment for Peripheral Arterial Disease

8/9/18: “We are very excited to partner with Lokai Medical and the company’s experienced sales team to help commercialize the PolarCath Balloon Dilatation System,” said Kevin Beedon, general manager and executive vice president of NuCryo Vascular. “NuCryo grew sales by 36 percent in 2017 vs. 2016 with an extremely small but dedicated direct sales team. The commercialization support and clinical expertise of Lokai Medical will help NuCryo continue its double-digit growth in the expanded markets we can now serve.”